- ISIN
- US7599101026
- CUSIP
- 759910102
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Mar 20, 1996
Highlights
- Market Cap
- $187.78M
- Enterprise Value
- $182.92M
- EPS (TTM)
- -$0.05
- Total Revenue (TTM)
- $43.26M
- Gross Profit (TTM)
- $25.98M
- EBITDA (TTM)
- -$1.51M
- Year Range
- $2.77 - $6.61
- Target Price
- $7.00
- ROA (TTM)
- -7.97%
- ROE (TTM)
- -13.47%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
KRMD Performance Chart
Repro Med Systems, Inc. (KRMD) is down 30.3% since the beginning of the year. At $4 per share, KRMD is trading 38.7% below its 52-week high of $7. Investors who bought $1,000 worth of KRMD shares 5 years ago would now be looking at an investment worth $882.
Loading charts...
Returns By Period
Repro Med Systems, Inc. (KRMD) has returned -30.29% so far this year and 45.16% over the past 12 months. Looking at the last ten years, KRMD has achieved an annualized return of 29.10%, outperforming the S&P 500 Index benchmark, which averaged 13.75% per year.
Repro Med Systems, Inc.
- 1D
- -0.49%
- 1M
- -0.49%
- YTD
- -30.29%
- 6M
- -28.70%
- 1Y
- 45.16%
- 3Y*
- 0.41%
- 5Y*
- -2.47%
- 10Y*
- 29.10%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
KRMD Monthly Returns History
Based on dividend-adjusted daily data since Mar 20, 1996, KRMD's average daily return is +0.39%, while the average monthly return is +3.82%. At this rate, an investment would double in approximately 1.5 years.
Historically, 47% of months were positive and 53% were negative. The best month was Apr 2003 with a return of +250.0%, while the worst month was Jan 2008 at -52.1%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 9 months.
On a daily basis, KRMD closed higher 28% of trading days. The best single day was Jul 9, 1999 with a return of +175.0%, while the worst single day was Oct 11, 2007 at -47.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.23% | -11.50% | -9.43% | -7.64% | 1.75% | -0.25% | -30.29% | ||||||
| 2025 | 14.03% | -21.18% | -26.59% | 8.27% | -1.82% | 32.59% | -3.35% | 21.97% | -9.24% | 3.39% | 49.49% | -1.86% | 50.91% |
| 2024 | -15.27% | 1.92% | 11.32% | -8.05% | -1.84% | 24.41% | -12.45% | 8.62% | 8.33% | 6.96% | 36.30% | -3.27% | 56.82% |
| 2023 | 11.48% | 4.77% | 1.20% | 5.92% | -18.01% | -5.87% | -24.64% | 0.77% | 3.05% | -15.93% | -0.44% | 8.63% | -31.23% |
| 2022 | 0.33% | 6.31% | -10.62% | -7.34% | -17.36% | 15.53% | -0.00% | -2.37% | -9.72% | 7.62% | 22.92% | 21.02% | 19.00% |
| 2021 | -32.89% | -3.96% | -9.28% | 7.10% | 13.26% | 8.43% | -26.35% | -4.69% | -12.31% | -12.63% | 38.15% | -12.79% | -50.17% |
Benchmark Metrics
Repro Med Systems, Inc. has an annualized alpha of 157.17%, beta of 0.34, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 21, 1996.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (62.95%) than losses (39.55%) - typical of diversified or defensive assets.
- Beta of 0.34 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 157.17%
- Beta
- 0.34
- R²
- 0.00
- Upside Capture
- 62.95%
- Downside Capture
- 39.55%
Return for Risk
Risk / Return Rank
KRMD ranks 64 for risk / return — better than 64% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Repro Med Systems, Inc. (KRMD) and compare them to S&P 500 Index.
| KRMD | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.87 | 2.39 | -1.52 |
Sortino ratioReturn per unit of downside risk | 1.66 | 3.25 | -1.59 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.43 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | 1.10 | 3.11 | -2.01 |
Martin ratioReturn relative to average drawdown | 2.21 | 14.38 | -12.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Repro Med Systems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Repro Med Systems, Inc. was 97.69%, occurring on Apr 3, 2003. Recovery took 3676 trading sessions.
The current Repro Med Systems, Inc. drawdown is 67.39%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2003 bear market2003 | -97.69%Apr 2003 | 3y 21d | 14y 7mo | 17y 8moMar 2000 - Nov 2017 |
Bear market2022 | -84.30%Jun 2022 | 2y 1mo | — | 6y 1moApr 2020 - now |
1999 bear market1999 | -78.67%Feb 1999 | 1y 3mo | 11mo 5d | 2y 2moOct 1997 - Jan 2000 |
COVID crash2020 | -48.44%Mar 2020 | 9d | 1mo | 1mo 9dMar 2020 - Apr 2020 |
Dot-com crash2000–2002 | -42.86%Mar 2000 | 7d | 6d | 13dFeb 2000 - Mar 2000 |
Drawdown Indicators
| KRMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.69% | -56.78% | -40.91% |
Max Drawdown (1Y)Largest decline over 1 year | -41.26% | -9.10% | -32.16% |
Max Drawdown (3Y)Largest decline over 3 years | -57.96% | -18.90% | -39.06% |
Max Drawdown (5Y)Largest decline over 5 years | -59.29% | -25.43% | -33.86% |
Max Drawdown (10Y)Largest decline over 10 years | -84.30% | -33.92% | -50.38% |
Current DrawdownCurrent decline from peak | -67.39% | 0.00% | -67.39% |
Average DrawdownAverage peak-to-trough decline | -59.13% | -10.72% | -48.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.46% | 1.97% | +18.49% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Repro Med Systems, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Repro Med Systems, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for KRMD relative to other companies in the Medical Instruments & Supplies industry. Currently, KRMD has a P/S ratio of 4.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for KRMD in comparison with other companies in the Medical Instruments & Supplies industry. Currently, KRMD has a P/B value of 11.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with KRMD
Add Repro Med Systems, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with KRMD